![](/img/cover-not-exists.png)
A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
Socinski, M. A.Volume:
17
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdj016
Date:
November, 2005
File:
PDF, 94 KB
english, 2005